{
    "organizations": [],
    "uuid": "36aca4cdd7cca9d42e0eab9e66558ce9ba89cb98",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-halozyme-reports-q4-earnings-per-s/brief-halozyme-reports-q4-earnings-per-share-0-85-idUSASB0C6II",
    "ord_in_thread": 0,
    "title": "BRIEF-Halozyme Reports Q4 Earnings Per Share $0.85",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 20 (Reuters) - Halozyme Therapeutics Inc:\n* HALOZYME REPORTS FOURTH QUARTER AND FULL-YEAR 2017 RESULTS\n* Q4 EARNINGS PER SHARE $0.85 * Q4 REVENUE $189.6 MILLION VERSUS $39 MILLION * REITERATED 2018 FINANCIAL GUIDANCE FOR NET REVENUE OF $115 MILLION TO $125 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-21T05:15:00.000+02:00",
    "crawled": "2018-02-21T21:27:42.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "halozyme",
        "therapeutic",
        "inc",
        "halozyme",
        "report",
        "fourth",
        "quarter",
        "result",
        "q4",
        "earnings",
        "per",
        "share",
        "q4",
        "revenue",
        "million",
        "versus",
        "million",
        "reiterated",
        "financial",
        "guidance",
        "net",
        "revenue",
        "million",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}